TNON · Tenon Medical, Inc. · Executive Compensation
$3.73
+0.03 (+0.81%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about the Company's ability to continue as a going concern for one year after the date that these financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.09M
Shares
667,047
Volume · Oct 6
422.6K
Avg daily vol (40 sessions)
10.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kevin Williamson | Chief Financial Officer | Appointed | 2024-08-27 |
| Steven Van Dick | Executive Vice President, Finance and Administration, Chief Financial Officer and Assistant Secretary | Retired | 2024-05-22 |
| Kristine Jacques | member of the Board | Appointed | 2024-04-01 |
| Frank Fischer | member of the Company's Board of Directors | Resigned | 2023-12-04 |